Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 28 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Over 55				Other				GMALL02 NCT00198978


2.		German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL01 NCT00198991


3.		Efficacy of G-CSF-Priming in Elderly AML Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Over 60				Other				AML-elderly 01/99 Trial NCT00199147


4.		AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				16 and over				Other				MK1-192 NCT00180128


5.		Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				0 to 75				Other				LPA 2005 NCT00408278


6.		Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 to 60				Other				AMLSG07-04 NCT00151242

Last Modified: 4/28/2008 First Published: 5/21/2007


7.		Phase II/III Randomized Study of Therapy Optimization Comprising Induction, Consolidation, and Intensification Regimens Followed By CNS Radiotherapy and Maintenance Therapy Comprising Thioguanine and Cytarabine in Pediatric Patients With Standard-Risk or High-Risk Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and under				Other				UCHM-AML-BFM-2004 UCHM-BfArM 4022064, NCT00111345, UCHM-DKH 50-2728, EU-20723, AML-BFM 2004

Last Modified: 6/5/2007 First Published: 5/23/2007


8.		Phase III Randomized Study of Arsenic Trioxide and Tretinoin Versus Combination Chemotherapy Comprising Tretinoin, Idarubicin, Mitoxantrone Hydrochloride, Methotrexate, and Mercaptopurine for Patients With Newly Diagnosed Acute Promyelocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				GIMEMA-DSL-APL0406 EUDRACT-2006-006188-22, APL0406, EU-20725, NCT00482833


9.		A Remission Induction Therapy and Risk-Oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				16 to 65				Other				NILG-AML 02/06 NCT00495287


10.		Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				60 and over				Other				CHUBX 2007/13 NCT00590837

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute